Etripamil is a calcium channel blocker designed to be administered intranasally to treat episodes of PSVT in an at-home setting. The Food and Drug Administration (FDA) has accepted for review the New ...
A Prescription Drug User Fee Act target date of September 14, 2025 has been assigned to the application. The Food and Drug Administration (FDA) has accepted for review the New Drug Application (NDA) ...
Your medicine cabinet could be packing more than just cold and flu relief. A groundbreaking new study found that a widely available over-the-counter nasal spray may help healthy adults fend off ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback